![]() |
Volumn 82, Issue 1-2, 2001, Pages 141-145
|
DNA mucosal HIV vaccine in humans
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
CD20 ANTIGEN;
CD3 ANTIGEN;
CD4 ANTIGEN;
CD45 ANTIGEN;
CD45RO ANTIGEN;
CD56 ANTIGEN;
CD57 ANTIGEN;
CD74 ANTIGEN;
CD8 ANTIGEN;
DNA VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
PROTEIN S 100;
SYNDECAN 1;
UNCLASSIFIED DRUG;
ANTIGEN BINDING;
ANTIGEN EXPRESSION;
BIOPSY;
CELL INFILTRATION;
CYTOTOXIC T LYMPHOCYTE;
DOSE RESPONSE;
DRUG EFFECT;
DRUG FORMULATION;
ENZYME IMMUNOASSAY;
HELPER CELL;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNIZATION;
IMMUNOHISTOCHEMISTRY;
IMMUNOPATHOLOGY;
IMMUNOREACTIVITY;
IMMUNOSTIMULATION;
INJECTION SITE;
JET INJECTION;
MONONUCLEAR CELL;
PRIORITY JOURNAL;
SHORT SURVEY;
VIRUS GENE;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0037196598
PISSN: 01681702
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-1702(01)00396-3 Document Type: Review |
Times cited : (44)
|
References (9)
|